蚓激酶与盐酸法舒地尔联用治疗急性脑梗死的临床研究

Clinical study on treatment of acute cerebral infarction with hydrochloric fasudil and lumbrukinase

目的评价蚓激酶与盐酸法舒地尔联用治疗急性脑梗死的疗效。方法将70例急性脑梗死的患者随机分成2组,治疗组和对照组各35例,对照组予以常规治疗,治疗组在常规治疗的基础上加用蚓激酶与盐酸法舒地尔。在治疗前和治疗后2周、4周和3个月分别进行神经功能缺损评分。结果治疗组对神经功能缺损的治疗效果优于对照组。结论蚓激酶与盐酸法舒地尔联用治疗急性脑梗死疗效确切。

Objective To evaluate the curative effect of hydrochloric fasudil associated with lumbrukinase treating acute cerebral infarction patients. Methods Seventy acute cerebral infarction patients as the objects of the study were divided into two groups randomly,control group（35 cases） were treated by conventional treatment,therapy group（35 cases） were treated by hydrochloric fasudil associated with lumbrukinase and conventional treatment, neurologic impairment scores before and after therapy two weeks,four weeks and three months were detected. Results In therapy group neurologic impairment score has more obvious advantage than that in control group. Conclusion The curative effect by hydrochloric fasudil associated with lumbrukinase treating the acute cerebral infarction patients is accurate.